DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study

References

• Hortobagyi GN, Singletary SE, McNeese MD. Treatment of locally advanced and inflammatory breast cancer. Breast Diseases, J Harris, 1996; 585–599
   Google Scholar
• Hortobagyi GN, Buzdar AU. Management of locally advanced breast cancer. Am J Clin Oncol Oct, 1988; 11: 597–601
   Google Scholar
• Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1–10
   PubMed Web of Science ®Google Scholar
• Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 1996; 78: 91–100
   PubMed Web of Science ®Google Scholar
• Robinson SP, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR. Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol 1998; 8: 197–207
   PubMed Web of Science ®Google Scholar
• Hylton NM. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 2001; 9: 321–332, vi
   Google Scholar
• Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10: 260–266
   PubMed Web of Science ®Google Scholar
• Knopp MV, von Tengg-Kobligk H, Choyke PL. Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring. Mol Cancer Ther 2003; 2: 419–426
   PubMed Web of Science ®Google Scholar
• Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 2000; 34: 208–219
   PubMed Web of Science ®Google Scholar
• Schnall MD. An overview of interpretation strategies for breast MR imaging. Magn Reson Imaging Clin N Am 2001; 9: 289–294, v–vi
   PubMedGoogle Scholar
• Schnall M, Orel S. Breast MR imaging in the diagnostic setting. Magn Reson Imaging Clin N Am 2006; 14: 329–337, vi
   Google Scholar
• Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999; 211: 101–110
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 2000; 12: 965–974
   PubMedGoogle Scholar
• Daniel BL, Yen YF, Glover GH, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ. Breast disease: Dynamic spiral MR imaging. Radiology 1998; 209: 499–509
   PubMedGoogle Scholar
• Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 1993; 11: 617–620
   PubMed Web of Science ®Google Scholar
• Liney GP, Gibbs P, Hayes C, Leach MO, Turnbull LW. Dynamic contrast-enhanced MRI in the differentiation of breast tumors: User-defined versus semi-automated region-of-interest analysis. J Magn Reson Imaging 1999; 10: 945–949
   PubMed Web of Science ®Google Scholar
• Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357–367
   PubMed Web of Science ®Google Scholar
• Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004; 83: 67–76
   PubMed Web of Science ®Google Scholar
• Julius T, Kemp SE, Kneeshaw PJ, Chaturvedi A, Drew PJ, Turnbull LW. MRI and conservative treatment of locally advanced breast cancer. Eur J Surg Oncol 2005; 31: 1129–1134
   PubMed Web of Science ®Google Scholar
• Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, Knopp MV, Delorme S. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol 2003; 13: 80–87
   PubMed Web of Science ®Google Scholar
• Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: Noninvasive monitoring with functional MR imaging pilot study. Radiology 2003; 228: 63–69
   PubMed Web of Science ®Google Scholar
• Drew PJ, Kerin MJ, Mahapatra T, Malone C, Monson JR, Turnbull LW, Fox JN. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001; 27: 617–620
   PubMed Web of Science ®Google Scholar
• Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: Correlation of dynamic MR features with prognostic factors. Eur Radiol 2003; 13: 2425–2435
   PubMed Web of Science ®Google Scholar
• Chang YC, Huang CS, Liu YJ, Chen JH, Lu YS, Tseng WY. Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. Phys Med Biol 2004; 49: 3593–3602
   PubMed Web of Science ®Google Scholar
• Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, Hewitt SM, Berman A, Steinberg SM, Liewehr DJ, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol 2006; 24: 769–777
   PubMed Web of Science ®Google Scholar
• Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, Leach MO, Husband JE. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006; 239: 361–374
   PubMed Web of Science ®Google Scholar
• Manton DJ, Chaturvedi A, Hubbard A, Lind MJ, Lowry M, Maraveyas A, Pickles MD, Tozer DJ, Turnbull LW. Neoadjuvant chemotherapy in breast cancer: Early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006; 94: 427–435
   PubMed Web of Science ®Google Scholar
• Wu L, McGough RJ, Arabe OA, Samulski TV. An RF phased array applicator designed for hyperthermia breast cancer treatments. Phys Med Biol 2006; 51: 1–20
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787–800
   PubMed Web of Science ®Google Scholar
• Kurland RJ, Shoop JD, Funkhouser GR. A kinetic model for time development of Gd-DTPA in relaxation enhancement (Abstr.). Magn Reson Imag 1989; 7: S177
   Google Scholar
• Belfi CA, Paul CR, Shan S, Ngo FQ. Comparison of the effects of hydralazine on tumor and normal tissue blood perfusion by MRI. Int J Radiat Oncol Biol Phys 1994; 29: 473–479
   Google Scholar
• Craciunescu OI, Das SK, McCauley RL, MacFall JR, Samulski TV. 3D numerical reconstruction of the hyperthermia induced temperature distribution in human sarcomas using DE-MRI measured tissue perfusion: Validation against non-invasive MR temperature measurements. Int J Hyperthermia 2001; 17: 221–239
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005; 11: 5206–5214
   PubMed Web of Science ®Google Scholar
• Taylor JS, Reddick WE. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. Adv Drug Deliv Rev 2000; 41: 91–110
   PubMed Web of Science ®Google Scholar
• Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999; 10: 254–259
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: Trade-off between spatial and temporal resolution. Radiology 2005; 236: 789–800
   PubMed Web of Science ®Google Scholar
• Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998; 16: 1057–1073
   Web of Science ®Google Scholar
• Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001; 13: 889–895
   PubMed Web of Science ®Google Scholar